Skip to main content
XERS
NASDAQ Life Sciences

Xeris Lifts 2026 Revenue Guidance to $395M–$405M After 44% Q3 Growth

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$10.75
Mkt Cap
$1.907B
52W Low
$5.25
52W High
$11.415
52W Position info
105% above low
Off High info
5.8% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

XERS has more than doubled off its 52-week low of $5.25.

Summary

Xeris raised full-year 2026 revenue guidance to $395M–$405M, though the release does not disclose the prior range, and lifted its 2030 revenue view to more than $1B. Q3 revenue jumped 44% year over year to $107.2M, driven by patient demand for Recorlev, and net income came in at $11.3M versus $0.6M a year earlier. Adjusted EBITDA rose $13.3M year over year to $30.8M, and gross margin expanded to 88% from 85%. The quarter follows a Q2 that showed 29% revenue growth but a $31.1M net loss from a non-cash debt extinguishment charge, so the swing to profit marks a clean step up. Next checkpoint is initiation of the XP-8121 Phase 3 study, targeted by year-end 2026.

At the time of this announcement, XERS was trading at $10.75 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $5.25 to $11.42. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

XERS - Latest Insights

XERS
Nov 05, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.67
Real-time Price: $17.00 info
Change: +$4.33 (+34%) info
Market Cap: $3.1B info
XERS
Nov 05, 2026, 2:22 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $13.17
Real-time Price: $17.00 info
Change: +$3.84 (+29%) info
Market Cap: $3.1B info
XERS
Nov 05, 2026, 7:12 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.48
Real-time Price: $17.00 info
Change: +$5.52 (+48%) info
Market Cap: $3.1B info
XERS
Nov 05, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $10.48
Real-time Price: $17.00 info
Change: +$6.52 (+62%) info
Market Cap: $3.1B info
XERS
Sep 09, 2026, 8:33 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.43
Real-time Price: $17.00 info
Change: +$8.57 (+102%) info
Market Cap: $3.1B info